RenovoRx RNXT
NASDAQ RNXT
$1.55 -0.01 (-0.64%)
At close: Oct 1, 2026 · 4:00 PM EDT

RenovoRx (RNXT) Non Operating Interest Expenses (2020 - 2021)

Updated

RenovoRx's Non Operating Interest Expenses was $208,000 in Q3 2021, up 11.8% from $186,000 a year earlier.

Analysis

RenovoRx (RNXT) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 401.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 351.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 107.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 186.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 141.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 96.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 132.00 Mn
10 RenovoRx 70.39 Mn 70.39 Mn 766,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 208,000.00
Sep 30, 2020 186,000.00
API Access

RenovoRx Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=RNXT&period=max&api_key=YOUR_API_KEY